Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group

Kanta Ka,Renaud Schiappa,Mario Terlizzi, Frederic Mallet,Etienne Martin,Marie-Eve Chand,Nicolas Demogeot,Didier Peiffert,Pascal Pommier,Magali Quivrin,Manon Kissel, Corentin Pasquier,Jonathan Khalifa,Alberto Bossi,Jean-Michel Hannoun-Levi,Pierre Blanchard

Radiotherapy and Oncology（2023）

引用 0|浏览20

暂无评分

摘要

•Largest French series on HDD brachytherapy boost for prostate cancer.•The quality of the data collection is one of its strengths.•This study shows the efficacy of HDD brachytherapy boost in intermediate and high risk prostate cancers at the national level and a homogeneity of practices in France.

查看译文

关键词

Prostate cancer,Radiotherapy,Brachytherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要